| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 531.84M | 428.49M | 349.89M | 280.04M | 206.68M |
| Gross Profit | 404.98M | 330.19M | 272.84M | 217.75M | 164.86M |
| EBITDA | -59.13M | -69.64M | -60.24M | -75.19M | -59.62M |
| Net Income | -71.82M | -69.24M | -61.26M | -90.18M | -64.20M |
Balance Sheet | |||||
| Total Assets | 1.34B | 1.13B | 972.56M | 871.22M | 852.53M |
| Cash, Cash Equivalents and Short-Term Investments | 705.13M | 522.01M | 545.01M | 443.20M | 421.13M |
| Total Debt | 19.13M | 20.16M | 36.18M | 40.79M | 47.32M |
| Total Liabilities | 453.93M | 356.38M | 293.43M | 246.45M | 213.95M |
| Stockholders Equity | 887.45M | 773.53M | 679.12M | 624.77M | 638.58M |
Cash Flow | |||||
| Free Cash Flow | 142.27M | 107.78M | 72.17M | 16.80M | 23.67M |
| Operating Cash Flow | 145.73M | 110.92M | 74.16M | 21.43M | 27.90M |
| Investing Cash Flow | -152.27M | -165.36M | -53.48M | -53.34M | -125.55M |
| Financing Cash Flow | 31.21M | 21.23M | 18.37M | 11.03M | 1.44M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $4.27B | -115.33 | -4.25% | ― | 35.87% | 85.20% | |
68 Neutral | $4.37B | -186.69 | -0.64% | ― | 11.63% | 50.72% | |
68 Neutral | $6.95B | -171.63 | -2.58% | ― | 50.91% | 54812.50% | |
65 Neutral | $4.41B | -100.89 | -5.17% | ― | 27.35% | 18.18% | |
62 Neutral | $4.97B | -67.13 | -8.65% | ― | 22.69% | -32.47% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | $7.29B | -92.98 | -9.82% | ― | 24.27% | 73.11% |
On February 26, 2026, JFrog announced that its board had authorized a share repurchase program of up to $300 million of its ordinary shares, signaling confidence in its strategy and long-term growth prospects. The company plans to fund the buybacks with cash on hand and future operating cash flows, and may execute repurchases in the open market or through privately negotiated transactions, subject to market conditions, regulatory requirements and a 30-day creditor objection period under Israeli corporate regulations.
The program is discretionary, imposes no obligation to repurchase a specific amount of stock and can be suspended, modified or discontinued at any time, allowing JFrog to balance returning capital to shareholders with maintaining flexibility for strategic investments. This move underscores the company’s strong balance sheet and consistent free cash flow generation, reinforcing its positioning in the competitive DevOps and software supply chain space while offering a potential boost to shareholder value.
The most recent analyst rating on (FROG) stock is a Hold with a $38.00 price target. To see the full list of analyst forecasts on JFrog stock, see the FROG Stock Forecast page.